Program Description:
As the clinical landscape for attention-deficit/hyperactivity disorder (ADHD) evolves, pharmacists serve as essential navigators for patients facing complex diagnostic journeys and significant barriers to care. The burden of undiagnosed or undertreated ADHD extends far beyond core symptoms, often manifesting as profound economic, academic, and psychological strain that diminishes a patient’s quality of life across the lifespan. To address these challenges, the current treatment armamentarium offers a diverse range of stimulants alongside increasingly utilized non-stimulant options, some featuring distinct pharmacokinetic profiles and novel delivery systems designed to optimize adherence. However, the management of these therapies has been recently complicated by persistent drug shortages and shifting regulatory requirements, creating a volatile environment for both providers and patients. Navigating these supply chain disruptions and implementing drug shortage protocols is a critical competency for pharmacists, who must be prepared to facilitate seamless formulation switching and class transitions while maintaining rigorous diversion monitoring. Through education on these logistical and clinical hurdles, pharmacists can proactively collaborate with the care team to ensure that medication access remains stable despite market instability. This activity provides the evidence-based strategies necessary to balance clinical efficacy with the practical realities of modern pharmacy practice, ultimately safeguarding patient outcomes in an era of unpredictable resource availability.
Target audience: Community Pharmacist
Type of activity: Application
Release date: June 15, 2026
Expiration date: August 15, 2026
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational
Objectives:
At the completion of this activity, participants will be able to:
- Explain the clinical manifestations of attention deficit hyperactivity disorder (ADHD) and treatment burden of undiagnosed or undertreated ADHD
- Differentiate the pharmacokinetic profiles of stimulants and non-stimulants for ADHD, including mechanisms of action, formulations, and adverse effect profiles
- Utilize drug-shortage tracking tools to proactively manage supply chain disruptions, formulation switching, and care team collaboration
Mary Accomando, PharmD, BCPP
Clinical Pharmacist Specialist - Pediatric Psychiatry
Cambridge Health Alliance
Somerville, MA
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-26-156-L01-P. The activity is available for CE credit through August 15, 2026.
Instructions for Completing the Activity and Receiving CPE Credit
To
receive CPE credit, participants must complete the pretest, review the activity in
its entirety, complete the posttest, and complete the online activity
evaluation. After successful completion of the online activity evaluation, you
can submit your credit to CPE Monitor. You may view your credit within 48 hours
at www.mycpemonitor.net. All participants must request credit before the
activity expiration date. CE credit will not be issued after this date.
Disclosures
Mary Accomando, PharmD, BCPP, has no relevant financial relationships with ineligible companies to disclose.
Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Brianna Winters; Lindsay Petrocelli; Susan Pordon; and Chloe Taccetta have no financial relationships with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
At least one anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not
constitute any form of professional advice or referral. Discussions concerning
drugs, dosages, and procedures may reflect the clinical experience of the
author(s) or they may be derived from the professional literature or other
sources and may suggest uses that are investigational in nature and not
approved labeling or indications. Participants are encouraged to refer to
primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
Privacy Policy and Terms of Use Information: